METHOTREXATE
NDC 55150-513, METHOTREXATE, injection, solution, from Eugia US LLC.
- Product NDC
- 55150-513
- Status
- Listed
- Labeler
- Eugia US LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201529
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55150-513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM250 mg/10mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55150-513-01 | 55150051301 | 1 VIAL in 1 CARTON (55150-513-01) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/63bb6fbf-dd59-4edc-af8f-d0c397ca1262
Use it
Look up 55150-513 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55150-513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55150-513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.